Telesis Bio, Inc.
TBIO · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $6,704 | $6,679 | $234,023 | $215,475 |
| - Cash | $3,720 | $6,397 | $10,723 | $1,570 |
| + Debt | $16,291 | $35,553 | $36,118 | $34,380 |
| Enterprise Value | $19,275 | $35,835 | $259,418 | $248,285 |
| Revenue | $1,566 | $1,550 | $3,440 | $6,977 |
| % Growth | 1% | -54.9% | -50.7% | – |
| Gross Profit | $1,009 | -$799 | $271 | $4,096 |
| % Margin | 64.4% | -51.5% | 7.9% | 58.7% |
| EBITDA | -$4,677 | -$10,544 | -$7,243 | -$16,019 |
| % Margin | -298.7% | -680.3% | -210.6% | -229.6% |
| Net Income | -$6,642 | -$12,585 | -$8,637 | -$17,687 |
| % Margin | -424.1% | -811.9% | -251.1% | -253.5% |
| EPS Diluted | -3.83 | -7.62 | -0.29 | -0.59 |
| % Growth | 49.7% | -2,527.6% | 50.8% | – |
| Operating Cash Flow | -$6,959 | -$5,346 | -$3,237 | -$7,312 |
| Capital Expenditures | -$55 | -$81 | -$502 | -$252 |
| Free Cash Flow | -$7,014 | -$5,427 | -$3,739 | -$7,564 |